However, they are characterized by a high CTA expression: as we previously described, 49-76% of synovial sarcomas express NY-ESO-1 and 51% of them coexpress NY-ESO-1 and MAGE-A4 and PRAME (72–74). Here, PRAME is linked to synovial sarcoma.